During the past decade, Aleksandre Aladashvili Clinic - LLC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 3 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aleksandre Aladashvili Clinic - LLC" #1 sponsor was "Alvotech Swiss AG" with 3 trials, followed by "Dompé Farmaceutici S.p.A" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Kowa Research Institute, Inc." with 2 trials sponsored and "American Regent, Inc." with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aleksandre Aladashvili Clinic - LLC" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator, "Cytel Inc." with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Aleksandre Aladashvili Clinic - LLC" are "Arthritis, Psoriatic" (2 trials), "Heart Failure" (2 trials), "Severe Hypertriglyceridemia" (2 trials), "Chronic Gout" (1 trials) and "Chronic Kidney Diseases" (1 trials). Many other conditions were trialed in "Aleksandre Aladashvili Clinic - LLC" in a lesser frequency.

Most popular intervention types in "Aleksandre Aladashvili Clinic - LLC" are "Drug" (12 trials), "Other" (3 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Adalimumab" (2 trials), "Fenofibrate" (2 trials), "Guselkumab" (2 trials) and "K-877" (2 trials). Other intervention names were less common.

The vast majority of trials in "Aleksandre Aladashvili Clinic - LLC" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Aleksandre Aladashvili Clinic - LLC". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Aleksandre Aladashvili Clinic - LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Aleksandre Aladashvili Clinic - LLC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".